---
title: "Nitisinone - Tyrosinemia Type I"
sidebar: mydoc_sidebar
permalink: db00348-mesh-d020176-1.html
toc: false 
---


Path ID: `DB00348_MESH_D020176_1`
{% include image.html url="images/db00348-mesh-d020176-1.png" file="db00348-mesh-d020176-1.png" alt="db00348-mesh-d020176-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C077073 | Nitisinone | Drug |
| UniProt:P32754 | 4-hydroxyphenylpyruvate dioxygenase | Protein |
| GO:0006572 | Tyrosine catabolic process | BiologicalProcess |
| MESH:C105171 | Fumarylacetoacetate | ChemicalSubstance |
| HP:0001394 | Cirrhosis | PhenotypicFeature |
| MESH:D020176 | Tyrosinemia type I | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Nitisinone | DECREASES ACTIVITY OF | 4-Hydroxyphenylpyruvate Dioxygenase |
| 4-Hydroxyphenylpyruvate Dioxygenase | POSITIVELY REGULATES | Tyrosine Catabolic Process |
| Tyrosine Catabolic Process | PRODUCES | Fumarylacetoacetate |
| Fumarylacetoacetate | CONTRIBUTES TO | Cirrhosis |
| Cirrhosis | MANIFESTATION OF | Tyrosinemia Type I |
|---------|-----------|---------|

Reference: 
  - [https://en.wikipedia.org/wiki/Tyrosinemia_type_I](https://en.wikipedia.org/wiki/Tyrosinemia_type_I)
  - [https://go.drugbank.com/drugs/DB00348#BE0000455](https://go.drugbank.com/drugs/DB00348#BE0000455)
